Peptide YY3-36
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Peptide YY3-36, covering 2009-01-14 to 2009-01-14. Get the full timeline:
Most recent: Clinical Trial Update: Inhibition of Food Intake in Response to Oral GLP-1 and Peptide YY3-36 [Phase 1, Phase 2]